Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 105893
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.105893
Table 6 Long-term microecological and immunological follow-up tracking, mean ± SD
Long-term follow-up indicators
Control group (n = 43)
Intervention group (n = 43)
P value
Recurrence rate, n (%)4 (9.3)1 (2.3)0.042
Microbiota stability indicators
Shannon diversity index3.62 ± 0.414.35 ± 0.38< 0.01
Microbial stability score0.64 ± 0.120.89 ± 0.15< 0.01
Immune function indicators
NK cell activity (%)12.4 ± 2.118.6 ± 2.5< 0.01
CD4+ T cell count (cells/μL)624 ± 86742 ± 93< 0.01
CD8+ T cell count (cells/μL)456 ± 72528 ± 65< 0.01
T cell subset ratio (CD4+/CD8+)1.36 ± 0.221.58 ± 0.250.02
Inflammatory markers
IL-6 (pg/mL)15.3 ± 2.79.6 ± 1.8< 0.01
TNF-α (pg/mL)12.4 ± 2.17.8 ± 1.5< 0.01
Nutritional status
Albumin levels (g/L)38.2 ± 3.641.5 ± 4.10.01
Body mass index changes-0.8 ± 0.30.2 ± 0.1< 0.01
Quality of life score68.4 ± 6.282.7 ± 5.8< 0.01